Pharmaceutical Products

Browse Popular Categories

Blog / Pharmaceutical Products

Pharmaceutical Products
Blog, Sergey Avramenko, July 26, 2018 64

In value terms, natural and reproduced glycosides and their salts imports stood at $1.2B in 2016. Overall, natural and reproduced glycosides and their salts imports continue to indicate a prominent in...

Pharmaceutical Products
Blog, Anna Sergeeva, July 26, 2018 68

In value terms, alkaloids imports stood at $2.1B in 2016. The total import value increased at an average annual rate of +1.6% from 2007 to 2016; however, the trend pattern remained relatively stable, ...

Pharmaceutical Products
Blog, Anna Sergeeva, July 26, 2018 63

In value terms, glands and other organs imports stood at $3.1B in 2016. Overall, glands and other organs imports continue to indicate a prominent growth. Over the period under review, global glands an...

 
Pharmaceutical Products
Blog, Sergey Avramenko, July 26, 2018 58

In value terms, natural and reproduced glycosides and their salts exports stood at $2B in 2016. In general, natural and reproduced glycosides and their salts exports continue to indicate a remarkable ...

Pharmaceutical Products
Blog, Sergey Avramenko, July 26, 2018 65

In value terms, alkaloids exports amounted to $1.9B in 2016. Overall, alkaloids exports continue to indicate a temperate setback. Global alkaloids export peaked of $3B in 2009; however, from 2010 to 2...

Pharmaceutical Products
Blog, Sergey Avramenko, July 26, 2018 56

In value terms, glands and other organs exports amounted to $4B in 2016. Overall, it indicated a prominent increase from 2007 to 2016: the total exports value increased at an average annual rate of +1...

 
Pharmaceutical Products
Blog, Sergey Avramenko, July 12, 2018 181

In 2016, EU vaccines for human medicine market was at 8.0 billion EUR, which was 831 million EUR (or 9%) less than the year before. There was a significant growth by 43% in 2015 due to price increase, after a fluctuations in market volume with an overall upward trend.

Pharmaceutical Products
Blog, Anna Sergeeva, June 26, 2018 130

In 2016, the antisera and other blood fractions market grew by 12% to 76 billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries. 

Pharmaceutical Products
Blog, Anna Sergeeva, May 28, 2018 68

In 2016, the global vitamin imports stood at 450K tonnes, lowering by -17.6% against the previous year figure. Overall, vitamin imports continue to indicate a relatively flat trend pattern. The growth...

 
Pharmaceutical Products
Blog, Anna Sergeeva, May 28, 2018 90

In 2016, the global imports of antisera stood at 1.4M tonnes, moving up by 468% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...

Pharmaceutical Products
Blog, Anna Sergeeva, May 28, 2018 73

In 2016, the global antibiotic imports stood at 123K tonnes, reducing by -20.8% against the previous year level. Overall, antibiotic imports continue to indicate a temperate setback. The pace of growt...

Pharmaceutical Products
Blog, Sergey Avramenko, May 28, 2018 86

In 2016, the global vitamin imports stood at 450K tonnes, lowering by -17.6% against the previous year figure. Overall, vitamin imports continue to indicate a relatively flat trend pattern. The growth...

 
Pharmaceutical Products
Blog, Anna Sergeeva, May 28, 2018 90

In 2016, the global imports of antisera stood at 1.4M tonnes, moving up by 468% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...

Pharmaceutical Products
Blog, Sergey Avramenko, May 28, 2018 86

In 2016, the global antibiotic imports stood at 123K tonnes, reducing by -20.8% against the previous year level. Overall, antibiotic imports continue to indicate a temperate setback. The pace of growt...

Pharmaceutical Products
Blog, Maria Fadeeva, November 03, 2016 1001

From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to 93,254 million USD in 2015. There was an annual increase of +12.8% throughout the analyzed period.

 
Pharmaceutical Products
Blog, Maria Fadeeva, October 24, 2016 1331

The global trade in antibiotics amounted to 11,187 million USD in 2015, showing some fluctuations over the period under review. A slight decline in 2009 was followed by a peak in 2011, until exports decreased again. Overall, there was an annual decrease of -0.1% from 2007 to 2015.

Pharmaceutical Products
Blog, Anna Sergeeva, August 10, 2016 688

After a four-year period of a steady decline, total imports of provitamins and vitamins in the EU Member States surged rapidly, reaching 2,023 million EUR in 2015. Data concerning the EU trade with non-EU countries shows that the EU remains a net importer of provitamins and vitamins.

Pharmaceutical Products
Blog, Irina Andreeva, July 14, 2016 472

The U.S. ranks fourth globally in exports on the biological product market with a 12% share (based on USD), following Switzerland (21%), Germany (18%), and Belgium (13%). The U.S. exported 17,378 million USD in 2015, which was 20% over the previous year's value.

 

  1   2   next >>